Ligand-induced tyrosine phosphorylation of cysteinyl leukotriene receptor 1 triggers internalization and signaling in intestinal epithelial cells

PLoS ONE

Volumn 5, Issue 12, 2010, Pages

  Parhamifar, Ladan ^a   Sime, Wondossen ^a   Yudina, Yuliana ^a   Vilhardt, Frederik ^b   Mörgelin, Matthias ^a   Sjölander, Anita ^a  

^a LUND UNIVERSITY   (Sweden)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CLATHRIN; CYCLOOXYGENASE 2; CYSTEINYL LEUKOTRIENE RECEPTOR 1 PROTEIN; CYSTEINYL LEUKOTRIENE RECEPTOR 2 PROTEIN; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RAB PROTEIN; RETINA S ANTIGEN; SMALL INTERFERING RNA; SUCROSE; TYROSINE; UNCLASSIFIED DRUG; ARRESTIN3; CYSTEINE; CYSTEINYL LEUKOTRIENE RECEPTOR 2; LEUKOTRIENE D4 RECEPTOR; LIGAND;

AMINO ACID METABOLISM; ARTICLE; CELL NUCLEUS MEMBRANE; CONTROLLED STUDY; DIMERIZATION; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INTERNALIZATION; INTESTINE EPITHELIUM CELL; LIGAND BINDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; CELL STRAIN CACO 2; CHEMISTRY; CYTOLOGY; EPITHELIUM CELL; INTESTINE; METABOLISM; PHOSPHORYLATION;

ARRESTINS; CACO-2 CELLS; CLATHRIN; CYSTEINE; DIMERIZATION; EPITHELIAL CELLS; HUMANS; INTESTINES; LIGANDS; PHOSPHORYLATION; RAB5 GTP-BINDING PROTEINS; RECEPTORS, LEUKOTRIENE; RNA, SMALL INTERFERING; TYROSINE;

EID: 78650844218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0014439     Document Type: Article

References (53)

1. Stenson WF (1990) Role of eicosanoids as mediators of inflammation in inflammatory bowel disease. Scand J Gastroenterol Suppl 172: 13-18.
2. Ekbom A, Helmick C, Zack M, Adami HO (1990) Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 323: 1228-1233.
3. Lynch KR, O'Neill GP, Liu Q, Im DS, Sawyer N, et al. (1999) Characterization of the human cysteinyl leukotriene CysLT1 receptor. Nature 399: 789-793.
4. Funk CD (2001) Prostaglandins and leukotrienes: advances in eicosanoid biology. Science 294: 1871-1875.
5. Serhan CN, Haeggström JZ, Leslie CC (1996) Lipid mediator networks in cell signaling: update and impact of cytokines. FASEB J 10: 1147-1158.
6. Mezhybovska M, Wikstrom K, Öhd JF, Sjölander A (2006) The inflammatory mediator leukotriene D4 induces beta-catenin signaling and its association with antiapoptotic Bcl-2 in intestinal epithelial cells. J Biol Chem 281: 6776-6784.
7. Wikström K, Öhd JF, Sjölander A (2003) Regulation of leukotriene-dependent induction of cyclooxygenase-2 and Bcl-2. Biochem Biophys Res Com 302: 330-335.
8. Öhd JF, Wikström K, Sjölander A (2000) Leukotrienes induce cell-survival signaling in intestinal epithelial cells. Gastroenterology 119: 1007-1018.
9. Paruchuri S, Hallberg B, Juhas M, Larsson C, Sjölander A (2002) Leukotriene D(4) activates MAPK through a Ras-independent but PKCepsilon-dependent pathway in intestinal epithelial cells. J Cell Sci 115: 1883-1893.
10. Paruchuri S, Sjölander A (2003) Leukotriene D4 mediates survival and proliferation via separate but parallel pathways in the human intestinal Epithelial cell line Int 407. J Biol Chem 278: 45577-45585.
11. Paruchuri S, Broom O, Dib K, Sjölander A (2005) The pro-inflammatory mediator leukotriene D4 induces phosphatidylinositol 3-kinase and Racdependent migration of intestinal epithelial cells. J Biol Chem 280: 13538-13544.
12. Nielsen Kamp C, Campbell J, Öhd JF, Mörgelin M, Riesbeck K, et al. (2005) A novel localization of the G-protein-coupled CysLT1 receptor in the nucleus of colorectal adenocarcinoma cells. Cancer Res 65: 732-742.
13. Öhd JF, Nielsen CK, Campbell J, Landberg G, Löfberg H, et al. (2003) Expression of the leukotriene D4 receptor CysLT1, COX-2, and other cell survival factors in colorectal adenocarcinomas. Gastroenterology 124: 57-70.
14. Magnusson C, Mezhybovska M, Lorinc E, Fernebro E, Nilbert M, et al. (2010) Low expression of CysLT1R and high expression of CysLT2R mediate good prognosis in colorectal cancer. Eur J Cancer 46: 826-835.
15. Magnusson C, Ehrnström R, Olsen J, Sjölander A (2007) An increased expression of cysteinyl leukotriene 2 receptor in colorectal adenocarcinomas correlates with high differentiation. Cancer Res 67: 9190-9198.
16. Naik S, Billington CK, Pascual RM, Deshpande DA, Stefano FP, et al. (2005) Regulation of cysteinyl leukotriene type 1 receptor internalization and signaling. J Biol Chem 280: 8722-8732.
17. Capra V, Ravasi S, Accomazzo MR, Citro S, Grimoldi M, et al. (2005) CysLT1 receptor is a target for extracellular nucleotide-induced heterologous desensitization: a possible feedback mechanism in inflammation. J Cell Sci 118: 5625-5636.
18. Deshpande DA, Pascual RM, Wang SW, Eckman DM, Riemer EC, et al. (2007) PKC-dependent regulation of the receptor locus dominates functional consequences of cysteinyl leukotriene type 1 receptor activation. FASEB J 21: 2335-2342.
19. Edwards SW, Tan CM, Limbird LE (2000) Localization of G-protein-coupled receptors in health and disease. Trends Pharmacol Sci 21: 304-308.
20. Cahill CM, Holdridge SV, Morinville A (2007) Trafficking of delta-opioid receptors and other G-protein-coupled receptors: implications for pain and analgesia. Trends Pharmacol Sci 28: 23-31.
21. Millar RP, Newton CL (2009) The year in G protein-coupled receptor research. Mol Endocrinol 24: 261-274.
22. Bai M (2004) Dimerization of G-protein-coupled receptors: roles in signal transduction. Cell Signal 16: 175-186.
23. Milligan G (2004) G protein-coupled receptor dimerization: function and ligand pharmacology. Mol Pharmacol 66: 1-7.
24. Ferguson SS (2001) Evolving concepts in G protein-coupled receptor endocytosis: the role in receptor desensitization and signaling. Pharmacol Rev 53: 1-24.
25. Hanyaloglu AC, von Zastrow M (2008) Regulation of GPCRs by endocytic membrane trafficking and its potential implications. Annu Rev Pharmacol Toxicol 48: 537-568.
26. Wolfe BL, Trejo J (2007) Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis. Traffic 8: 462-470.
27. García Lopez MA AMA, Lamaze C, Martínez-A C, Fischer T (2009) Inhibition of dynamin prevents CCL2-mediated endocytosis of CCR2 and activation of ERK1/2. Cell Signal 21: 1748-1757.
28. Chen Z, Gaudreau R, Le Gouill C, Rola-Pleszczynski M, Stankova J (2004) Agonist-induced internalization of leukotriene B(4) receptor 1 requires Gprotein- coupled receptor kinase 2 but not arrestins. Mol Pharmacol 66: 377-386.
29. Seachrist JL, Ferguson SS (2003) Regulation of G protein-coupled receptor endocytosis and trafficking by Rab GTPases. Life Sci 74: 225-235.
30. Sonnichsen B, De Renzis S, Nielsen E, Rietdorf J, Zerial M (2000) Distinct membrane domains on endosomes in the recycling pathway visualized by multicolor imaging of Rab4, Rab5, and Rab11. J Cell Biol 149: 901-914.
31. Schwartz SL, Cao C, Pylypenko O, Rak A, Wandinger-Ness A (2007) Rab GTPases at a glance. J Cell Sci 120: 3905-3910.
32. Marchese A, Paing MM, Temple BR, Trejo J (2008) G protein-coupled receptor sorting to endosomes and lysosomes. Annu Rev Pharmacol Toxicol 48: 601-629.
33. Goetzl EJ (2007) Diverse pathways for nuclear signaling by G protein-coupled receptors and their ligands. FASEB J 21: 638-642.
34. Zhu T, Gobeil F, Vazquez-Tello A, Leduc M, Rihakova L, et al. (2006) Intracrine signaling through lipid mediators and their cognate nuclear Gprotein- coupled receptors: a paradigm based on PGE2, PAF, and LPA1 receptors. Can J Phys Pharmacol 84: 377-391.
35. Gobeil F, Jr., Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, et al. (2002) Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ Res 90: 682-689.
36. Shmuel M, Nodel-Berner E, Hyman T, Rouvinski A, Altschuler Y (2007) Caveolin 2 regulates endocytosis and trafficking of the M1 muscarinic receptor in MDCK epithelial cells. Mol Biol Cell 18: 1570-1585.
37. Syme CA, Zhang L, Bisello A (2006) Caveolin-1 regulates cellular trafficking and function of the glucagon-like Peptide 1 receptor. Mol Endocrinol 20: 3400-3411.
38. Insel PA, Head BP, Ostrom RS, Patel HH, Swaney JS, et al. (2005) Caveolae and lipid rafts: G protein-coupled receptor signaling microdomains in cardiac myocytes. Ann N Y Acad Sci 1047: 166-172.
39. Ostrom RS, Insel PA (2004) The evolving role of lipid rafts and caveolae in G protein-coupled receptor signaling: implications for molecular pharmacology. Br J Pharmacol 143: 235-245.
40. Henle G, Deinhardt F (1957) The establishment of strains of human cells in tissue culture. J Immunol 79: 54-59.
41. Parhamifar L, Jeppsson B, Sjölander A (2005) Activation of cPLA2 is required for leukotriene D4-induced proliferation in colon cancer cells. Carcinogenesis 26: 1988-1998.
42. Söderberg O, Leuchowius KJ, Gullberg M, Jarvius M, Weibrecht I, et al. (2008) Characterizing proteins and their interactions in cells and tissues using the in situ proximity ligation assay. Methods 45: 227-232.
43. Carlemalm E, Villiger W, Hobot JA, Acetarin JD, Kellenberger E (1985) Low temperature embedding with Lowicryl resins: two new formulations and some applications. J Microsc 140: 55-63.
44. Baschong W, Lucocq JM, Roth J (1985) "Thiocyanate gold": small (2-3 nm) colloidal gold for affinity cytochemical labeling in electron microscopy. Histochemistry 83: 409-411.
45. Jiang Y, Borrelli LA, Kanaoka Y, Bacskai BJ, Boyce JA (2007) CysLT2 receptors interact with CysLT1 receptors and down-modulate cysteinyl leukotriene dependent mitogenic responses of mast cells. Blood 110: 3263-3270.
46. Benmerah A, Poupon V, Cerf-Bensussan N, Dautry-Varsat A (2000) Mapping of Eps15 domains involved in its targeting to clathrin-coated pits. J Biol Chem 275: 3288-3295.
47. Paruchuri S, Mezhybovska M, Juhas M, Sjölander A (2006) Endogenous production of leukotriene D4 mediates autocrine survival and proliferation via CysLT1 receptor signalling in intestinal epithelial cells. Oncogene 25: 6660-6665.
48. Tohgo A, Choy EW, Gesty-Palmer D, Pierce KL, Laporte S, et al. (2003) The stability of the G protein-coupled receptor-beta-arrestin interaction determines the mechanism and functional consequence of ERK activation. J Biol Chem 278: 6258-6267.
49. Hopkins AL, Groom CR (2002) The druggable genome. Nat Rev Drug Discov 1: 727-730.
50. Drews J (2000) Drug discovery: a historical perspective. Science 287: 1960-1964.
51. Joos GF (2008) Which patients with asthma could benefit from using antileukotriene drugs: an evidence based review. Pol Arch Med Wewn 118: 689-690.
52. Thompson MD, Siminovitch KA, Cole DE (2008) G protein-coupled receptor pharmacogenetics. Methods Mol Biol 448: 139-185.
53. Paruchuri S, Jiang Y, Feng C, Francis SA, Plutzky J, et al. (2008) Leukotriene E4 activates peroxisome proliferator-activated receptor gamma and induces prostaglandin D2 generation by human mast cells. J Biol Chem 283: 16477-16487.